Funding support for clinical trials

Funding for clinical trials to evaluate new drugs, devices, clinical guidance, approaches and technologies aimed at stopping the spread of COVID-19. Projects may range from proof-of-concept to large-scale trials. Funding cannot be used for animal studies.

$30M (U.S.)
Eligibility (if available)

Principal investigator must be at level of Assistant Professor or equivalent.

Foreign participation? (where known)
Date of announcement
Date application deadline